Sun Pharma launches cancer drug INFUGEM in US market Farhat Nasim9 April 2019 10:05 AM ISTSun Pharma said INFUGEM uses its proprietary technology which allows cytotoxic oncology products to be premixed in a sterile environment and supplied...
Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine Meghna A Singhania17 March 2019 1:33 PM ISTNew Delhi: In a major setback to Sun Pharmaceuticals Ltd, the drug price regulator the National Pharmaceutical Pricing Authority(NPPA) has refused to...
Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer Farhat Nasim27 Feb 2019 9:30 AM ISTThe company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection...